TP53 and esophageal squamous cell carcinoma: The interactions of the lowest quartile of serum folate level with p16 or p53 methylation were significantly associated with increased risk of ESCC (OR = 2.96, 95% CI 1.45–6.05; OR = 2.34, 95% CI 1.15–4.75).